Odelle Technology

Odelle Technology Odelle Technology provide market access and reimbursement solutions Medtech Biotech and Digital EU.

We can guide you through the medical device regulatory and reimbursement processes in the public and private healthcare sectors in the UK. You will talk face to face with the best people for your platform and you’ll get the best result you can for your product. We will optimize your distribution matrix by accessing the different cross layered networks within the UK Healthcare system using a variety of channel partners

https://www.youtube.com/watch?v=Ax145T_THp8
27/01/2026

https://www.youtube.com/watch?v=Ax145T_THp8

Podcast with Jenny Rivers, Director of Research & Development at Barts Health NHS Trust and Dr Suthesh Sivapalaratnam, Clinical Senior Lecturer in Haematolog...

26/01/2026

How to Use German NUB Reimbursement Without Getting Trapped After nearly two decades of operational data, one conclusion is unavoidable: German NUB reimbursement is not a neutral innovation gateway. It selectively rewards certain types of technologies, structurally disadvantages others, and—most c...

26/01/2026

How venture capital really works in MedTech and IVD. Academic evidence on VC risk pricing, reimbursement systems, DRGs and scalable exits.

26/01/2026

How Germany’s 2026 sepsis quality rules change reimbursement, and what diagnostics, AI and workflow technologies must prove to get paid.

26/01/2026

Germany’s Hybrid-DRG system explained: how inpatient and outpatient coding is merged, why it matters, and which MedTech and digital health technologies benefit most.

26/01/2026

Belgium’s DRG system explained: why APR-DRGs are designed for cost control, why implants sit outside tariffs, and how innovators should really use DRGs.

26/01/2026

How reimbursement works in Poland: NFZ payment rules, DRG (JGP) hospital tariffs, outpatient reimbursement, and AOTMiT HTA pathways for MedTech, IVD, and AI.

26/01/2026

France 2030 medical device funding explained: how to apply for implantable devices and surgical robotics, with eligibility rules, TRL 4–9 criteria, and funding details.

26/01/2026

How Medicare DMHT codes are shaping U.S. digital therapeutics reimbursement in 2025, what PDTx may bring next, and how companies can align to get paid

26/01/2026

A 2025 scoping review explaining how NICE Early Value Assessments work, what evidence is accepted, and why EVA enables real-world learning in the NHS.

Address

Oxford
OX277SG

Alerts

Be the first to know and let us send you an email when Odelle Technology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram